Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
Peter J Illingworth,1 Robert Lahoud,1 Frank Quinn,1 Kendal Chidwick,2 Claire Wilkinson,2 Gavin Sacks1 1IVFAustralia, Greenwich, Sydney, NSW, Australia; 2Scientific Affairs, Merck Serono Australia Pty Ltd, Frenchs Forest, Sydney, NSW, Australia Purpose: Evaluation of patients’ e...
Main Authors: | Illingworth PJ, Lahoud R, Quinn F, Chidwick K, Wilkinson C, Sacks G |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2014-06-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/single-arm-observational-study-of-the-ease-of-use-of-a-redesigned-pen--a17120 |
Similar Items
-
Aktuelles: Neuer Follitropin-alfa-Pen getestet
Published: (2011-01-01) -
Aktuelles: Neuer Follitropin-alfa-Pen getestet
Published: (2011-01-01) -
A redesigned follitropin alfa pen injector for infertility: results of a market research study
by: Abbotts C, et al.
Published: (2011-06-01) -
Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
by: Nawroth F, et al.
Published: (2015-04-01) -
Recombinant follitropin alfa/lutropin alfa in fertility treatment
by: Ahmed Gibreel, et al.
Published: (2009-12-01)